1. A retrospective cohort study: pre‐operative oral enteral nutritional optimisation for Crohnʼs disease in a UK tertiary IBD centre. Issue 4 (20th June 2022) Authors: Meade, Susanna; Patel, Kamal V.; Luber, Raphael P.; O'Hanlon, Dearbhaile; Caracostea, Andra; Pavlidis, Polychronis; Honap, Sailish; Anandarajah, Cheran; Griffin, Nyree; Zeki, Sebastian; Ray, Shuvra; Mawdsley, Joel; Samaan, Mark A.; Anderson, Simon H.; Darakhshan, Amir; Adams, Katie; Williams, And... Journal: Alimentary pharmacology & therapeutics Issue: Volume 56:Issue 4(2022) Page Start: 646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch. Issue 5 (5th July 2021) Authors: Luber, Raphael P.; O'Neill, Rhona; Singh, Sukhpreet; Sharma, Esha; Cunningham, Georgina; Honap, Sailish; Meade, Susanna; Ray, Shuvra; Anderson, Simon H.; Mawdsley, Joel; Sanderson, Jeremy D.; Samaan, Mark A.; Arkir, Zehra; Irving, Peter M. Journal: Alimentary pharmacology & therapeutics Issue: Volume 54:Issue 5(2021) Page Start: 678 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Current Practices in Ileal Pouch Surveillance for Patients With Ulcerative Colitis: A Multinational, Retrospective Cohort Study. (24th December 2018) Authors: Samaan, Mark A; Forsyth, Katrina; Segal, Jonathan P; De Jong, Djuna; Vleugels, Jasper L A; Elkady, Soad; Kabir, Misha; Campbell, Samantha; Kok, Klaartje; Armstrong, David G; Penez, Lawrence; Arenaza, Aitor P; Seward, Edward; Vega, Roser; Mehta, Shameer; Rahman, Farooq; McCartney, Sara; Bloom, Stu... Journal: Journal of Crohn's and colitis Issue: Volume 13:Number 6(2019) Page Start: 735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Depression, anxiety, and stress among inflammatory bowel disease patients during COVID‐19: A UK cohort study. Issue 1 (5th January 2022) Authors: Luber, Raphael P; Duff, Alexa; Pavlidis, Polychronis; Honap, Sailish; Meade, Susanna; Ray, Shuvra; Anderson, Simon H; Mawdsley, Joel; Samaan, Mark A; Irving, Peter M Journal: JGH open Issue: Volume 6:Issue 1(2022) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal response. Issue 3 (11th July 2019) Authors: Samaan, Mark A; Birdi, Siddharth; Morales, Maria Sierra; Honap, Sailish; Tamilarasan, Aravind Gokul; Cunningham, Georgina; Koumoutsos, Ioannis; Ray, Shuvra; Mawdsley, Joel; Anderson, Simon H C; Sanderson, Jeremy; Irving, Peter M Journal: Frontline gastroenterology Issue: Volume 11:Issue 3(2020) Page Start: 188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic. Issue 5 (16th June 2020) Authors: Kennedy, Nicholas A; Hansen, Richard; Younge, Lisa; Mawdsley, Joel; Beattie, R Mark; Din, Shahida; Lamb, Christopher A; Smith, Philip J; Selinger, Christian; Limdi, Jimmy; Iqbal, Tariq H; Lobo, Alan; Cooney, Rachel; Brain, Oliver; Gaya, Daniel R; Murray, Charles; Pollok, Richard; Kent, Alexandra;... Journal: Frontline gastroenterology Issue: Volume 11:Issue 5(2020) Page Start: 343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OWE-03 Higher serum golimumab concentrations are associated with combined clinical-biochemical remission: results from the GO-LEVEL study. Issue 2 (June 2019) Authors: Samaan, Mark A; Cunningham, Georgina; Tamilarasan, Aravind Gokul; Rawstron, Krystal; Hawash, Karim; Beltran, Luisa; Koumoutsos, Ioannis; Ray, Shuvra; Mawdsley, Joel; Anderson, Simon H; Sanderson, Jeremy D; Arkir, Zehra; Irving, Peter M Journal: Gut Issue: Volume 68:Issue 2(2019) Page Start: A62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P19 Risankizumab in crohn's disease: real world experience from a pre-approval access program. (19th June 2022) Authors: Dawson, Patrick; Sharma, Esha; Dart, Robin; Lim, Samuel; Ray, Shuvra; Anderson, Simon; Mawdsley, Joel; Irving, Peter; Samaan, Mark Journal: Gut Issue: Volume 71(2022)Supplement 1 Page Start: A45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P1 Prevalence of steroid use in inflammatory bowel disease outpatient setting and measures to prevent side-effects. (19th June 2022) Authors: Agorogianni, Alexandra; Dias, Shiluka; Anderson, Simon; Mawdsley, Joel; Samaan, Mark Journal: Gut Issue: Volume 71(2022)Supplement 1 Page Start: A35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P42 The UCEIS score can help predict the long-term outcome of UC patients in clinical remission. (19th June 2022) Authors: Markopoulos, Panagiotis; Ghuman, Sundeep; Zeki, Sebastian; Dart, Robin; Ray, Shuvra; Anderson, Simon; Mawdsley, Joel; Irving, Peter; Samaan, Mark Journal: Gut Issue: Volume 71(2022)Supplement 1 Page Start: A58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗